Want to see JP:4524 full AI Analyst Report?
Morishita Jintan Co., Ltd. (4524) Price & Analysis
4524 Stock Chart & Stats
- Day’s Range
- JPY 2,181.00 - JPY 2,195.00
- 52-Week Range
- JPY 2,100.00 - JPY 2,390.00
- Previous Close
- JPY 2,218.00
- Volume
- 1,200
- Average Volume (3M)
- 1,427
- Market Cap
- JPY 8.95B
- Enterprise Value
- JPY 9.06B
- Total Cash (Recent Filing)
- JPY 1.52B
- Total Debt (Recent Filing)
- JPY 1.75B
- Price to Earnings (P/E)
- 11.4
- Beta
- 0.33
- Next Earnings
- Nov 11, 2026
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- Mar 30, 2027
- Dividend Yield
- 2.96%
Bulls Say, Bears Say
Bulls Say
Conservative Balance Sheet
Low leverage and a large equity cushion reduce solvency risk and give the company room to fund product development or absorb volatility. The 2026 debt increase bears monitoring, but current capitalization supports resilience over the next several quarters.
Historical Revenue Expansion
Multi-year revenue growth indicates established demand for the company’s healthcare products, while resilient gross profit suggests its product portfolio retains reasonable pricing and scale benefits despite the latest annual setback.
Improved Operating Cash Flow
The strong operating cash-flow rebound shows that the core business can generate meaningful cash internally. If sustained, this would improve funding capacity for operations and investment without relying heavily on additional borrowing.
Bears Say
Recent Revenue Contraction
The latest top-line decline signals a pause in demand or market expansion and creates a weaker starting point for near-term growth. Sustained contraction could reduce operating leverage and limit the company’s ability to improve profitability.
Volatile Free Cash Flow
Inconsistent free cash flow indicates that reported earnings do not reliably convert into discretionary funds after investment needs. This limits financial flexibility and could constrain shareholder returns or strategic investment during weaker periods.
Moderate Profitability
Moderate earnings on the current revenue base suggest limited margin depth and a smaller buffer against input costs, competition, or weaker demand. This may make sustained earnings growth more dependent on renewed sales expansion.
4524 FAQ
What was Morishita Jintan Co., Ltd.’s price range in the past 12 months?
What is Morishita Jintan Co., Ltd.’s market cap?
When is Morishita Jintan Co., Ltd.’s upcoming earnings report date?
How were Morishita Jintan Co., Ltd.’s earnings last quarter?
Is Morishita Jintan Co., Ltd. overvalued?
Does Morishita Jintan Co., Ltd. pay dividends?
What is Morishita Jintan Co., Ltd.’s EPS estimate?
How many shares outstanding does Morishita Jintan Co., Ltd. have?
What happened to Morishita Jintan Co., Ltd.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Morishita Jintan Co., Ltd.?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Morishita Jintan Co., Ltd.
Morishita Jintan Co., Ltd. is a Japanese enterprise that manufactures and distributes a diverse array of products, encompassing pharmaceuticals, quasi-pharmaceuticals, medical devices, and food items. The company's operations are divided into two main segments: Healthcare Business and Capsule Business. The Healthcare Business division is responsible for the production and sale of its proprietary Jintan branded goods, and also provides original equipment manufacturing (OEM) services for dietary supplements, cosmetic products, and various food items. Concurrently, the Capsule Business division handles both original equipment and design manufacturing (OEM/ODM) for pharmaceutical and food sectors, in addition to innovating and developing capsules for industrial applications. Established in 1893, the company's headquarters are located in Osaka, Japan.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Yuji Morishita
- Employees
- 359
- Website
- www.jintan.co.jp
- Address
- 1-2-40, Tamatsukuri, Chuo, OS, 540-8566, JP
Morishita Jintan Co., Ltd. (4524) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 6 | 4 | 12 |
| Technical Analysis | 4 | 4 | 2 |
| Moving Averages | 2 | 0 | 10 |